Zhejiang Wolwo Stock Soars 10.89%, Hits Intraday High of CNY 23.88

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.89% on June 29, 2026. The stock reached an intraday high of CNY 23.88, reflecting a robust day of trading for the large-cap company within the Pharmaceuticals & Biotechnology sector. In comparison to the broader market, Zhejiang Wolwo's one-day performance notably outpaced the China Shanghai Composite, which rose by only 1.16%. Over the past week, the stock has shown a 7.27% increase, contrasting with a decline of 2.14% in the composite index. Despite a challenging year-to-date performance of -16.68%, the company has demonstrated resilience with a year-over-year profit increase of 36.3%. Key financial metrics indicate a return on equity (ROE) of 14.93% and a price-to-book ratio of 3.60, suggesting a fair valuation. Additionally, the company boasts a dividend yield of 1.17%, appealing to income-focused investors. Overall, Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. continues to navigate a complex market landscape while achieving notable intraday highs.